Clinical significance of upregulated Rho GTPase activating protein 12 causing resistance to tyrosine kinase inhibitors in hepatocellular carcinoma

Figure 2 Single-cell RNA sequencing data analysis of 18 primary hepatocellular carcinoma and non-hepatocellular carcinoma tissue samples in GSE149614. A: Cell distribution of hepatocellular carcinoma and non-hepatocellular carcinoma groups in the samples; B: Distribution of included samples. Different colors represent different tissue samples; C: Main cell types; D: Rho GTPase activating protein 12 expression distribution. ARHGAP12: Rho GTPase activating protein 12; HCC: Hepatocellular carcinoma; UMAP: Uniform manifold approximation and projection.